menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Clinical Applications of Raltegravir for HIV Therapy

close
Clinical Applications of Raltegravir for HIV Therapy
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    We are getting our first in-depth look at some of the research behind raltegravir, a powerful therapy for multi-drug resistant HIV infection already approved by the FDA. How is this raltegravir data impacting current clinical strategies for attacking the virus in multi-drug resistant patients? Host Dr. Mark Nolan Hill probes this question and much more with Dr. Roy Steigbigel, professor of medicine and pathology, molecular genetics and microbiology, and pharmacological sciences, and founding director of the Comprehensive AIDS Center at the State University of New York at Stony Brook.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    We are getting our first in-depth look at some of the research behind raltegravir, a powerful therapy for multi-drug resistant HIV infection already approved by the FDA. How is this raltegravir data impacting current clinical strategies for attacking the virus in multi-drug resistant patients? Host Dr. Mark Nolan Hill probes this question and much more with Dr. Roy Steigbigel, professor of medicine and pathology, molecular genetics and microbiology, and pharmacological sciences, and founding director of the Comprehensive AIDS Center at the State University of New York at Stony Brook.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 9/18/20